Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 5,399 | $67.32 | $363,460.68 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 3 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 5,696 | $51.95 | $295,907.20 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 2 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 7,222 | $50.95 | $367,960.90 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,430 | $0.00 Strike: $67.32 | $0.00 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · derivative · entry 13 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,397 Underlying: Common Stock · 10,430 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,570 | $0.00 Strike: $67.32 | $0.00 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · derivative · entry 12 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,827 Underlying: Common Stock · 9,570 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,611 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · derivative · entry 11 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,611 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 37,248 | $0.00 Strike: $51.95 | $0.00 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · derivative · entry 10 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,248 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 30,763 | $178.59 | $5,494,093.37 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 9 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,615.6729 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.00 - $179.63, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 13,163 | $180.50 | $2,375,933.35 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 8 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,378.6729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 - $181.45, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 8,840 | $178.59 | $1,578,772.73 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 7 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,541.6729 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.00 - $179.63, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 8,750 | $178.59 | $1,562,699.25 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 6 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,381.6729 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.00 - $179.63, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 8,100 | $180.50 | $1,462,057.29 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 5 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,131.6729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 - $181.45, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 9,570 | $67.32 | $644,252.40 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 4 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,231.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 10,430 | $67.32 | $702,147.60 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 3 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,661.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 10,611 | $50.95 | $540,630.45 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 2 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,231.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:02 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 37,248 | $51.95 | $1,935,033.60 |
DisclosureSEC source: 0001225208-22-009602 · doc4.xml · nonDerivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,620.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 19:07 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,148 | $0.00 Strike: $36.97 | $0.00 |
DisclosureSEC source: 0001225208-22-009597 · doc4.xml · derivative · entry 3 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,148 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 19:07 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
SaleCommon Stock | 17,855 | $178.57 | $3,188,356.64 |
DisclosureSEC source: 0001225208-22-009597 · doc4.xml · nonDerivative · entry 2 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,545.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.015 - $179.490, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 19:07 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
Exercise / conversionCommon Stock | 22,148 | $36.97 | $818,811.56 |
DisclosureSEC source: 0001225208-22-009597 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,400.8948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2022 Filed Aug 15, 2022 19:37 UTC |
KALENKA ROBERT FCorporate Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 983 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009513 · doc4.xml · derivative · entry 3 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 983 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 13, 2022 983 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 13, 2022 983 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 13, 2022 983 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 13, 2022 983 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| August 13, 2022 Filed Aug 15, 2022 19:37 UTC |
KALENKA ROBERT FCorporate Vice President
|
Tax withholdingCommon Stock | 502 | $183.22 | $91,976.44 |
DisclosureSEC source: 0001225208-22-009513 · doc4.xml · nonDerivative · entry 2 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,102.4097 Read SEC document |
| August 13, 2022 Filed Aug 15, 2022 19:37 UTC |
KALENKA ROBERT FCorporate Vice President
|
Exercise / conversionCommon Stock | 983 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009513 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,604.4097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 13, 2022 983 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 09:37 UTC |
Matlin LauraVP, Deputy GC and CGO
|
GrantCommon Stock | 964 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009460 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,684.696 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:36 UTC | GrantCommon Stock | 34,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009458 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,513.0271 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
|
| August 10, 2022 Filed Aug 12, 2022 09:36 UTC |
DALY RICHARD JDirector · Executive Chairman
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009456 · doc4.xml · nonDerivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,555.9949 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:37 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantCommon Stock | 1,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009464 · doc4.xml · nonDerivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,272.799 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:37 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
GrantCommon Stock | 7,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009463 · doc4.xml · nonDerivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,372.6729 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:37 UTC |
Reese EdmundCorporate VP and CFO
|
GrantCommon Stock | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009462 · doc4.xml · nonDerivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:37 UTC |
PERRY CHRISTOPHER JOHNPresident
|
GrantCommon Stock | 9,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009461 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,332.528 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:36 UTC |
KALENKA ROBERT FCorporate Vice President
|
GrantCommon Stock | 2,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009459 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,621.4097 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:36 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
GrantCommon Stock | 2,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009457 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,252.8948 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 13:36 UTC |
Carey Thomas PCorporate VP
|
GrantCommon Stock | 4,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009455 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,288 F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 6, 2023. Read SEC document |
| July 11, 2022 Filed Jul 24, 2023 20:54 UTC |
Reese EdmundCorporate VP and CFO
|
GrantCommon Stock | 17.01 | $148.75 | $2,530.24 |
DisclosureSEC source: 0001225208-23-007647 · doc5.xml · nonDerivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,970.46 F1 · shares: Represents shares of Broadridge common stock acquired through dividend reinvestment during the fiscal year. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 76 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008711 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,039 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:35 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 76 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008716 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,316 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008712 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
keller brettDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008713 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,421 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
keller brettDirector
|
GrantCommon Stock | 27 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008713 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,414 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 16:35 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008709 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,737 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008715 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,058 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008715 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,057 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008717 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,047 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008717 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,040 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008714 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,495.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008714 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,483.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:35 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008710 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,341 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| July 06, 2022 Filed Jul 24, 2023 20:54 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
GrantCommon Stock | 18.76 | $143.62 | $2,694.31 |
DisclosureSEC source: 0001225208-23-007646 · doc5.xml · nonDerivative · entry 1 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,228.98 F1 · shares: Represents shares of Broadridge common stock acquired through dividend reinvestment during the fiscal year. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:03 UTC |
keller brettDirector
|
GrantCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008192 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,387 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:03 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008195 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,031 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:03 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008194 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.